Evidence supporting the use of: Alpha-Linolenic Acid
For the health condition: Osteoporosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Alpha-Linolenic Acid (ALA) is an omega-3 fatty acid found primarily in plant sources such as flaxseed, chia seeds, and walnuts. There is some scientific interest in the potential role of ALA in bone health, including osteoporosis, primarily due to its anti-inflammatory properties and influence on bone metabolism. Preclinical studies (animal and in vitro) suggest that omega-3 fatty acids may help reduce bone loss and improve bone density by modulating inflammatory cytokines and affecting osteoclast and osteoblast activity. However, most of these studies are conducted with long-chain omega-3s (EPA and DHA) rather than ALA specifically.

Human studies directly investigating the effect of ALA on osteoporosis are limited and generally of low quality. Some observational studies have found weak associations between higher dietary ALA intake and improved bone mineral density or reduced fracture risk, but these findings are not consistent and do not establish causation. Randomized controlled trials examining ALA supplementation specifically for osteoporosis prevention or treatment are scarce. In contrast, there is more robust evidence supporting the benefit of marine-based omega-3s (EPA/DHA), but this cannot be directly extrapolated to ALA due to differences in metabolism and biological activity.

In summary, while there is some scientific rationale and preliminary evidence suggesting a possible benefit of ALA for bone health, the evidence supporting its use for osteoporosis is currently limited and inconclusive. It is not a standard or established therapy for this condition.

More about Alpha-Linolenic Acid
More about Osteoporosis

Products containing Alpha-Linolenic Acid

We currently have no products on Vitabase that contain this ingredient.